http://scigraph.springernature.com/journal.1094201
ISSN0167-6997 | 1573-0646
DIMENSIONShttps://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1094201
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"alternateName": "Novel Anti-Cancer Therapeutics and Therapies",
"contentRating": [
{
"author": "snip",
"ratingValue": "0.8550000190734863",
"type": "Rating"
},
{
"author": "sjr",
"ratingValue": "1.253999948501587",
"type": "Rating"
}
],
"description": "The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. Investigational New Drugs provides a forum for the rapid dissemination of information on new anticancer agents. The papers published are of interest to the medical chemist, toxicologist, pharmacist, pharmacologist, biostatistician and clinical oncologist. Investigational New Drugs provides the fastest possible publication of new discoveries and results for the whole community of scientists developing anticancer agents.
Each issue contains original articles dealing with anticancer drug development. Other sections are devoted to invited review articles and letters to the editor. The journal also affords the opportunity to publish the proceedings of special workshops and symposia devoted to the development of new anticancer agents. Provided they add to the understanding of the investigational agents, the journal is not adverse to publishing clinical trials with negative results.
Investigational New Drugs cuts across all the usual lines or subdisciplines, providing a locus for the presentation of relevant investigations and the discussion of critical questions appropriate to the entire field of new anticancer drug development.
",
"editor": [
{
"familyName": "Rowinsky",
"givenName": "Eric K.",
"type": "Person"
}
],
"id": "sg:journal.1094201",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"issn": [
"0167-6997",
"1573-0646"
],
"license": "Hybrid",
"name": "Investigational New Drugs",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"94201"
]
},
{
"name": "lccn_id",
"type": "PropertyValue",
"value": [
"sn 84009586"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"8309330"
]
},
{
"name": "nsd_ids_id",
"type": "PropertyValue",
"value": [
"442160"
]
},
{
"name": "era_ids_id",
"type": "PropertyValue",
"value": [
"14781"
]
}
],
"publisher": {
"name": "Springer US",
"type": "Organization"
},
"publisherImprint": "Springer",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1094201"
],
"sdDataset": "journals",
"sdDatePublished": "2022-08-04T17:25",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/journal/journal_0.jsonl",
"startYear": "1983",
"type": "Periodical",
"url": "https://link.springer.com/journal/10637"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1094201'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1094201'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1094201'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1094201'
This table displays all metadata directly associated to this object as RDF triples.
61 TRIPLES
21 PREDICATES
28 URIs
24 LITERALS
10 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:journal.1094201 | schema:alternateName | Novel Anti-Cancer Therapeutics and Therapies |
2 | ″ | schema:contentRating | N778b0921100a4a91a0988bb330238939 |
3 | ″ | ″ | N90e56a36cbed41af9a624bf849a6ea6b |
4 | ″ | schema:description | <p>The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. <i>Investigational New Drugs</i> provides a forum for the rapid dissemination of information on new anticancer agents. The papers published are of interest to the medical chemist, toxicologist, pharmacist, pharmacologist, biostatistician and clinical oncologist. <i>Investigational New Drugs</i> provides the fastest possible publication of new discoveries and results for the whole community of scientists developing anticancer agents.<br/><br/>Each issue contains original articles dealing with anticancer drug development. Other sections are devoted to invited review articles and letters to the editor. The journal also affords the opportunity to publish the proceedings of special workshops and symposia devoted to the development of new anticancer agents. Provided they add to the understanding of the investigational agents, the journal is not adverse to publishing clinical trials with negative results.<br/><br/><i>Investigational New Drugs</i> cuts across all the usual lines or subdisciplines, providing a locus for the presentation of relevant investigations and the discussion of critical questions appropriate to the entire field of new anticancer drug development.</p> |
5 | ″ | schema:editor | N215e1f61f0fe4e60bfa6806ca23839c3 |
6 | ″ | schema:inLanguage | en |
7 | ″ | schema:isAccessibleForFree | false |
8 | ″ | schema:issn | 0167-6997 |
9 | ″ | ″ | 1573-0646 |
10 | ″ | schema:license | Hybrid |
11 | ″ | schema:name | Investigational New Drugs |
12 | ″ | schema:productId | N07759ecce1f449f3a8cb0e99304c3f79 |
13 | ″ | ″ | N23c9be9d39a44bf48813ab9277e7ad25 |
14 | ″ | ″ | N9ae5f23c380c45b3b904c4495f423a2a |
15 | ″ | ″ | Ne2cb635803b3471c866a47cac11228d5 |
16 | ″ | ″ | Nf3759aa99ccb48039f4d8c3f7122123c |
17 | ″ | schema:publisher | N84f9382f867e473eb0b4f738771c8494 |
18 | ″ | schema:publisherImprint | Springer |
19 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1094201 |
20 | ″ | schema:sdDatePublished | 2022-08-04T17:25 |
21 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
22 | ″ | schema:sdPublisher | Nec3114817508427098395d8cbcbe4d0d |
23 | ″ | schema:startYear | 1983 |
24 | ″ | schema:url | https://link.springer.com/journal/10637 |
25 | ″ | sgo:license | sg:explorer/license/ |
26 | ″ | sgo:sdDataset | journals |
27 | ″ | rdf:type | schema:Periodical |
28 | N07759ecce1f449f3a8cb0e99304c3f79 | schema:name | lccn_id |
29 | ″ | schema:value | sn 84009586 |
30 | ″ | rdf:type | schema:PropertyValue |
31 | N215e1f61f0fe4e60bfa6806ca23839c3 | rdf:first | Nfe10cb8271bf4834b1e1ff042a0b22c6 |
32 | ″ | rdf:rest | rdf:nil |
33 | N23c9be9d39a44bf48813ab9277e7ad25 | schema:name | era_ids_id |
34 | ″ | schema:value | 14781 |
35 | ″ | rdf:type | schema:PropertyValue |
36 | N6a9e835e78fb41f593a62c2d073a6c09 | rdf:first | sjr |
37 | ″ | rdf:rest | rdf:nil |
38 | N778b0921100a4a91a0988bb330238939 | schema:author | N6a9e835e78fb41f593a62c2d073a6c09 |
39 | ″ | schema:ratingValue | 1.253999948501587 |
40 | ″ | rdf:type | schema:Rating |
41 | N82c0693e7474486e86689862ef881faa | rdf:first | snip |
42 | ″ | rdf:rest | rdf:nil |
43 | N84f9382f867e473eb0b4f738771c8494 | schema:name | Springer US |
44 | ″ | rdf:type | schema:Organization |
45 | N90e56a36cbed41af9a624bf849a6ea6b | schema:author | N82c0693e7474486e86689862ef881faa |
46 | ″ | schema:ratingValue | 0.8550000190734863 |
47 | ″ | rdf:type | schema:Rating |
48 | N9ae5f23c380c45b3b904c4495f423a2a | schema:name | dimensions_id |
49 | ″ | schema:value | 94201 |
50 | ″ | rdf:type | schema:PropertyValue |
51 | Ne2cb635803b3471c866a47cac11228d5 | schema:name | nsd_ids_id |
52 | ″ | schema:value | 442160 |
53 | ″ | rdf:type | schema:PropertyValue |
54 | Nec3114817508427098395d8cbcbe4d0d | schema:name | Springer Nature - SN SciGraph project |
55 | ″ | rdf:type | schema:Organization |
56 | Nf3759aa99ccb48039f4d8c3f7122123c | schema:name | nlm_unique_id |
57 | ″ | schema:value | 8309330 |
58 | ″ | rdf:type | schema:PropertyValue |
59 | Nfe10cb8271bf4834b1e1ff042a0b22c6 | schema:familyName | Rowinsky |
60 | ″ | schema:givenName | Eric K. |
61 | ″ | rdf:type | schema:Person |